111 related articles for article (PubMed ID: 20423099)
1. NMR analyses of the interaction between CCR5 and its ligand using functional reconstitution of CCR5 in lipid bilayers.
Yoshiura C; Kofuku Y; Ueda T; Mase Y; Yokogawa M; Osawa M; Terashima Y; Matsushima K; Shimada I
J Am Chem Soc; 2010 May; 132(19):6768-77. PubMed ID: 20423099
[TBL] [Abstract][Full Text] [Related]
2. Molecular anatomy of CCR5 engagement by physiologic and viral chemokines and HIV-1 envelope glycoproteins: differences in primary structural requirements for RANTES, MIP-1 alpha, and vMIP-II Binding.
Navenot JM; Wang ZX; Trent JO; Murray JL; Hu QX; DeLeeuw L; Moore PS; Chang Y; Peiper SC
J Mol Biol; 2001 Nov; 313(5):1181-93. PubMed ID: 11700073
[TBL] [Abstract][Full Text] [Related]
3. Elucidation of the CCR1- and CCR5-binding modes of MIP-1α by application of an NMR spectra reconstruction method to the transferred cross-saturation experiments.
Yoshiura C; Ueda T; Kofuku Y; Matsumoto M; Okude J; Kondo K; Shiraishi Y; Shimada I
J Biomol NMR; 2015 Dec; 63(4):333-340. PubMed ID: 26472202
[TBL] [Abstract][Full Text] [Related]
4. A chimeric MIP-1alpha/RANTES protein demonstrates the use of different regions of the RANTES protein to bind and activate its receptors.
Blanpain C; Buser R; Power CA; Edgerton M; Buchanan C; Mack M; Simmons G; Clapham PR; Parmentier M; Proudfoot AE
J Leukoc Biol; 2001 Jun; 69(6):977-85. PubMed ID: 11404385
[TBL] [Abstract][Full Text] [Related]
5. I-TAC/CXCL11 is a natural antagonist for CCR5.
Petkovic V; Moghini C; Paoletti S; Uguccioni M; Gerber B
J Leukoc Biol; 2004 Sep; 76(3):701-8. PubMed ID: 15178708
[TBL] [Abstract][Full Text] [Related]
6. Analyzing ligand and small molecule binding activity of solubilized GPCRs using biosensor technology.
Navratilova I; Dioszegi M; Myszka DG
Anal Biochem; 2006 Aug; 355(1):132-9. PubMed ID: 16762304
[TBL] [Abstract][Full Text] [Related]
7. Paramagnetic proteoliposomes containing a pure, native, and oriented seven-transmembrane segment protein, CCR5.
Mirzabekov T; Kontos H; Farzan M; Marasco W; Sodroski J
Nat Biotechnol; 2000 Jun; 18(6):649-54. PubMed ID: 10835604
[TBL] [Abstract][Full Text] [Related]
8. Molecular modeling and site-directed mutagenesis of CCR5 reveal residues critical for chemokine binding and signal transduction.
Zhou N; Luo Z; Hall JW; Luo J; Han X; Huang Z
Eur J Immunol; 2000 Jan; 30(1):164-73. PubMed ID: 10602038
[TBL] [Abstract][Full Text] [Related]
9. CCR5 has an expanded ligand-binding repertoire and is the primary receptor used by MCP-2 on activated T cells.
Ruffing N; Sullivan N; Sharmeen L; Sodroski J; Wu L
Cell Immunol; 1998 Nov; 189(2):160-8. PubMed ID: 9790730
[TBL] [Abstract][Full Text] [Related]
10. Large-scale expression and purification of the major HIV-1 coreceptor CCR5 and characterization of its interaction with RANTES.
Nisius L; Rogowski M; Vangelista L; Grzesiek S
Protein Expr Purif; 2008 Oct; 61(2):155-62. PubMed ID: 18588983
[TBL] [Abstract][Full Text] [Related]
11. The seventh transmembrane domain of cc chemokine receptor 5 is critical for MIP-1beta binding and receptor activation: role of MET 287.
Youn BS; Yu KY; Alkhatib G; Kwon BS
Biochem Biophys Res Commun; 2001 Mar; 281(3):627-33. PubMed ID: 11237703
[TBL] [Abstract][Full Text] [Related]
12. The activation mechanism of chemokine receptor CCR5 involves common structural changes but a different network of interhelical interactions relative to rhodopsin.
Springael JY; de Poorter C; Deupi X; Van Durme J; Pardo L; Parmentier M
Cell Signal; 2007 Jul; 19(7):1446-56. PubMed ID: 17320349
[TBL] [Abstract][Full Text] [Related]
13. The molecular cloning and functional expression of the dog CCR5.
Mosley M; Pullen S; Botham A; Gray A; Napier C; Mansfield R; Holbrook M
Vet Immunol Immunopathol; 2006 Oct; 113(3-4):415-20. PubMed ID: 16806494
[TBL] [Abstract][Full Text] [Related]
14. Functional dynamics of deuterated β2 -adrenergic receptor in lipid bilayers revealed by NMR spectroscopy.
Kofuku Y; Ueda T; Okude J; Shiraishi Y; Kondo K; Mizumura T; Suzuki S; Shimada I
Angew Chem Int Ed Engl; 2014 Dec; 53(49):13376-9. PubMed ID: 25284766
[TBL] [Abstract][Full Text] [Related]
15. Evidence for negative binding cooperativity within CCR5-CCR2b heterodimers.
El-Asmar L; Springael JY; Ballet S; Andrieu EU; Vassart G; Parmentier M
Mol Pharmacol; 2005 Feb; 67(2):460-9. PubMed ID: 15509716
[TBL] [Abstract][Full Text] [Related]
16. Analysis of second messenger pathways stimulated by different chemokines acting at the chemokine receptor CCR5.
Leach K; Charlton SJ; Strange PG
Biochem Pharmacol; 2007 Sep; 74(6):881-90. PubMed ID: 17645873
[TBL] [Abstract][Full Text] [Related]
17. MIP-1alpha utilizes both CCR1 and CCR5 to induce osteoclast formation and increase adhesion of myeloma cells to marrow stromal cells.
Oba Y; Lee JW; Ehrlich LA; Chung HY; Jelinek DF; Callander NS; Horuk R; Choi SJ; Roodman GD
Exp Hematol; 2005 Mar; 33(3):272-8. PubMed ID: 15730850
[TBL] [Abstract][Full Text] [Related]
18. Identification of amino acid residues crucial for chemokine receptor dimerization.
Hernanz-Falcón P; Rodríguez-Frade JM; Serrano A; Juan D; del Sol A; Soriano SF; Roncal F; Gómez L; Valencia A; Martínez-A C; Mellado M
Nat Immunol; 2004 Feb; 5(2):216-23. PubMed ID: 14716309
[TBL] [Abstract][Full Text] [Related]
19. Protecting from R5-tropic HIV: individual and combined effectiveness of a hammerhead ribozyme and a single-chain Fv antibody that targets CCR5.
Cordelier P; Kulkowsky JW; Ko C; Matskevitch AA; McKee HJ; Rossi JJ; Bouhamdan M; Pomerantz RJ; Kari G; Strayer DS
Gene Ther; 2004 Nov; 11(22):1627-37. PubMed ID: 15295615
[TBL] [Abstract][Full Text] [Related]
20. Identification of a postendocytic sorting sequence in CCR5.
Delhaye M; Gravot A; Ayinde D; Niedergang F; Alizon M; Brelot A
Mol Pharmacol; 2007 Dec; 72(6):1497-507. PubMed ID: 17855654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
